SLC30A8 and type 2 diabetes mellitus: Both PROX1 and SLC30A8, together with other T2D risk loci (IL6R, TCF7L2, HNF1A) and 21 genes reported as associated with plasma lipids in humans [22] were predicted as target genes of NCOA2 in our study.